Feature Type | Standardized | Nominal ANOVA | ||||
---|---|---|---|---|---|---|
mRNA | C6-ceramide | CTRPv2 | pan-cancer | AAC | 0.015 | 0.7 |
mRNA | elocalcitol | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | THZ-2-49 | GDSC1000 | pan-cancer | AAC | -0.011 | 0.7 |
mRNA | Axitinib | GDSC1000 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | LBW242 | CCLE | pan-cancer | AAC | -0.018 | 0.7 |
mRNA | ML203 | CTRPv2 | pan-cancer | AAC | 0.014 | 0.7 |
mRNA | BRD-K79669418 | CTRPv2 | pan-cancer | AAC | 0.019 | 0.7 |
mRNA | ZM-447439 | GDSC1000 | pan-cancer | AAC | -0.013 | 0.7 |
mRNA | tanespimycin:gemcitabine (1:1 mol/mol) | CTRPv2 | pan-cancer | AAC | 0.013 | 0.7 |
mRNA | BEC | CTRPv2 | pan-cancer | AAC | -0.032 | 0.7 |